Chaperone-mediated autophagy is a tumor-suppressive mechanism in hepatocellular carcinoma

Khushbu Patel1, Begoña Zapateria1, Alexander J Ledet2

  • 1Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Medicine and The Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Cell Reports
|May 28, 2026
PubMed

Insights

Chaperone-mediated autophagy (CMA) loss promotes liver cancer by impairing cell-type-specific tumor suppression. CMA dysregulation and STAG2 accumulation drive hepatocarcinogenesis, highlighting CMA

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Chaperone-mediated autophagy (CMA) is a vital lysosomal pathway for maintaining proteostasis and adapting to stress.
  • CMA function declines with aging and metabolic diseases, which are risk factors for hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To investigate the cell-type-dependent role of CMA in hepatocellular carcinoma (HCC) development.
  • To identify molecular mechanisms by which CMA loss contributes to hepatocarcinogenesis.

Main Methods:

  • Utilized genetically engineered mouse models with specific deletions of the CMA regulator LAMP2A in hepatocytes or T cells within an MYC-driven, TP53-deficient HCC model.
  • Performed proteomic profiling to identify CMA substrates.
  • Validated findings in human HCC tissues.

Main Results:

  • Hepatocyte-specific CMA loss accelerated early malignant transformation.
  • T cell-specific CMA deficiency initially impaired tumor immunity but later supported tumor growth.
  • Accumulation of STAG2, a cohesin complex component, was observed in CMA-dysregulated hepatocytes and human HCC tissues.
  • STAG2 accumulation was linked to cell cycle dysregulation and increased proliferation.

Conclusions:

  • CMA plays a dual role in suppressing liver tumorigenesis, dependent on both hepatocytes and the immune system.
  • STAG2 is a key CMA-controlled molecule implicated in HCC development.
  • Targeting CMA or STAG2 may offer therapeutic strategies for HCC.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...